Plasticity and impact of the central renin-angiotensin system during development of ethanol dependence

Journal of Molecular Medicine

Volumn 85, Issue 10, 2007, Pages 1089-1097

  Sommer, W H ^a   Rimondini, R ^b   Marquitz, M ^c   Lidstrom J ^a   Siems, W E ^d   Bader, M ^e   Heilig, M ^a  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^d LEIBNIZ INSTITUT FÜR MOLEKULARE PHARMAKOLOGIE   (Germany)

^e MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Alcoholism; Angiotensin converting enzyme inhibitor; Animal model; Gene expression; Transgenic rats

Indexed keywords

ANGIOTENSIN 1A RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE; SPIRAPRIL;

ALCOHOL CONSUMPTION; ALCOHOL INTOXICATION; ALCOHOL WITHDRAWAL; ALCOHOLISM; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DRUG DOSE INCREASE; MACROGLIA; NONHUMAN; NUCLEUS ACCUMBENS; PLASTICITY; PREFRONTAL CORTEX; PROTEIN EXPRESSION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENIC RAT;

ADAPTATION, PHYSIOLOGICAL; ALCOHOLISM; ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANGIOTENSINOGEN; ANIMALS; ANIMALS, GENETICALLY MODIFIED; CENTRAL NERVOUS SYSTEM; DISEASE MODELS, ANIMAL; ENALAPRIL; ETHANOL; HUMANS; NEURONAL PLASTICITY; RATS; RATS, WISTAR; RECEPTORS, ANGIOTENSIN; RENIN-ANGIOTENSIN SYSTEM; RNA, ANTISENSE;

EID: 34748853806     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-007-0255-5     Document Type: Article

References (47)

1. von Bohlen und Halbach HO (2005) The renin-angiotensin system in the mammalian central nervous system. Curr Protein Pept Sci 6:355-371
2. Fuxe K, Ganten D, Hokfelt T, Bolme P (1976) Immunohistochemical evidence for existence of angiotensin Ii containing nerve-terminals in brain and spinal-cord in rat. Neurosci Lett 2:229-234
3. Mendelsohn FA, Jenkins TA, Berkovic SF (1993) Effects of angiotensin II on dopamine and serotonin turnover in the striatum of conscious rats. Brain Res 613:221-229
4. Aguilera G, Young WS, Kiss A, Bathia A (1995) Direct regulation of hypothalamic corticotropin-releasing-hormone neurons by angiotensin II. Neuroendocrinology 61:437-444
5. Bader M, Peters J, Baltatu O, Muller DN, Luft FC, Ganten D (2001) Tissue renin-angiotensin systems: new insights from experimental animal models in hypertension research. J Mol Med 79:76-102
6. Weisinger RS, Blair-West JR, Denton DA, McBurnie MI (1999) Angiotensin II stimulates intake of ethanol in C57BL/6J mice. Physiol Behav 67:369-376
7. Weisinger RS, Blair-West JR, Burns P, Denton DA (1999) Intracerebroventricular infusion of angiotensin II increases water and ethanol intake in rats. Am J Physiol 277:R162-R172
8. Fitts DA (1993) Angiotensin and captopril increase alcohol intake. Pharmacol Biochem Behav 45:35-43
9. Garrib A, Peters T (1998) Angiotensin-converting enzyme (ACE) gene polymorphism and alcoholism. Biochem Soc Trans 26:S136
10. Maul B, Siems WE, Hoehe MR, Grecksch G, Bader M, Walther T (2001) Alcohol consumption is controlled by angiotensin II. FASEB J 15:1640-1642
11. Maul B, Krause W, Pankow K, Becker M, Gembardt F, Alenina N, Walther T, Bader M, Siems WE (2005) Central angiotensin II controls alcohol consumption via its AT1 receptor. FASEB J 19:1474-1481
12. Grupp LA (1992) Effects of angiotensin II and an angiotensin converting enzyme inhibitor on alcohol intake in P and NP rats. Pharmacol Biochem Behav 41:105-108
13. Saba L, Bhave SV, Grahame N, Bice P, Lapadat R, Belknap J, Hoffman PL, Tabakoff B (2006) Candidate genes and their regulatory elements: alcohol preference and tolerance. Mamm Genome 17:669-688
14. Rodd ZA, Bertsch BA, Strother WN, Le-Niculescu H, Balaraman Y, Hayden E, Jerome RE, Lumeng L, Nurnberger JI, Edenberg HJ Jr, McBride WJ, Niculescu AB (2006) Candidate genes, pathways and mechanisms for alcoholism: an expanded convergent functional genomics approach. Pharmacogenomics J 6:1-3
15. Dackis CA, O'Brien CP (2005) Neurobiology of addiction: treatment and public policy ramifications. Nat Neurosci 8:1431-1436
16. Koob GF, Le Moal M (2005) Plasticity of reward neurocircuitry and the 'dark side' of drug addiction. Nat Neurosci 8:1442-1444
17. Rimondini R, Arlinde C, Sommer W, Heilig M (2002) Long-lasting increase in voluntary ethanol consumption and transcriptional regulation in the rat brain after intermittent exposure to alcohol. FASEB J 16:27-35
18. Roberts AJ, Heyser CJ, Cole M, Griffin P, Koob GF (2000) Excessive ethanol drinking following a history of dependence: animal model of allostasis. Neuropsychopharmacology 22:581-594
19. Breese GR, Overstreet DH, Knapp DJ (2005) Conceptual framework for the etiology of alcoholism: a "kindling"/stress hypothesis. Psychopharmacology (Berl) 178:367-380
20. Rimondini R, Sommer W, Heilig M (2003) A temporal threshold for induction of persistent alcohol preference: behavioral evidence in a rat model of intermittent intoxication. J Stud Alcohol 64:445-449
21. Heyser CJ, Schulteis G, Durbin P, Koob GF (1998) Chronic acamprosate eliminates the alcohol deprivation effect while having limited effects on baseline responding for ethanol in rats. Neuropsychopharmacology 18:125-133
22. Spanagel R, Zieglgansberger W (1997) Anti-craving compounds for ethanol: new pharmacological tools to study addictive processes. Trends Pharmacol Sci 18:54-59
23. Egli M (2005) Can experimental paradigms and animal models be used to discover clinically effective medications for alcoholism? Addict Biol 10:309-319
24. Valdez GR, Koob GF (2004) Allostasis and dysregulation of corticotropin-releasing factor and neuropeptide Y systems: implications for the development of alcoholism. Pharmacol Biochem Behav 79:671-689
25. Sommer WH, Rimondini R, Hansson AC, Heilig M (2007) Up-regulation of voluntary alcohol intake, behavioral sensitivity to stress, and amygdala Crhr1 expression following a history of dependence. Biol Psychiatry DOI 10.1016/j.biopsych.2007.01.010
26. Heilig M, Koob GF (2007) A critical role for corticotropin-releasing factor (CRF) in alcohol dependence and relapse to alcohol seeking. Trends Neurosci 30:399-406
27. Takai S, Song K, Tanaka T, Okunishi H, Miyazaki M (1996) Antinociceptive effects of angiotensin-converting enzyme inhibitors and an angiotensin II receptor antagonist in mice. Life Sci 59:L331-L336
28. Schinke M, Baltatu O, Bohm M, Peters J, Rascher W, Bricca G, Lippoldt A, Ganten D, Bader M (1999) Blood pressure reduction and diabetes insipidus in transgenic rats deficient in brain angiotensinogen. Proc Natl Acad Sci USA 96:3975-3980
29. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates. Academic, San Diego
30. Vandesompele J, De PK, Pattyn F, Poppe B, Van RN, De PA, Speleman F (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3:RESEARCH0034
31. Bjork K, Saarikoski ST, Arlinde C, Kovanen L, Osei-Hyiaman D, Ubaldi M, Reimers M, Hyytia P, Heilig M, Sommer WH (2006) Glutathione-S-transferase expression in the brain: possible role in ethanol preference and longevity. FASEB J 20:1826-1835
32. O'Dell LE, Roberts AJ, Smith RT, Koob GF (2004) Enhanced alcohol self-administration after intermittent versus continuous alcohol vapor exposure. Alcohol Clin Exp Res 28:1676-1682
33. Hansson AC, Bermudez-Silva FJ, Malinen H, Hyytia P, Sanchez-Vera I, Rimondini R, de Rodriguez FF, Kunos G, Sommer WH, Heilig M (2006) Genetic impairment of frontocortical endocannabinoid degradation and high alcohol preference. Neuropsychopharmacology 32:117-126
34. Hallberg M, Nyberg F (2003) Neuropeptide conversion to bioactive fragments-an important pathway in neuromodulation. Curr Protein Pept Sci 4:31-44
35. Lingham T, Perlanski E, Grupp LA (1990) Angiotensin converting enzyme inhibitors reduce alcohol consumption: some possible mechanisms and important conditions for its therapeutic use. Alcohol Clin Exp Res 14:92-99
36. Naranjo CA, Kadlec KE, Sanhueza P, Woodley-Remus D, Sellers EM (1991) Enalapril effects on alcohol intake and other consummatory behaviors in alcoholics. Clin Pharmacol Ther 50:96-106
37. Robertson JM, Harding S, Grupp LA (1994) The reduction in alcohol intake produced by enalapril is not attenuated by centrally administered angiotensin inhibitors. Alcohol 11:295-299
38. Spinosa G, Perlanski E, Leenen FH, Stewart RB, Grupp LA (1988) Angiotensin converting enzyme inhibitors: animal experiments suggest a new pharmacological treatment for alcohol abuse in humans. Alcohol Clin Exp Res 12:65-70
39. Sybertz EJ, Watkins RW, Ahn HS, Baum T, La RP, Patrick J, Leitz F (1987) Pharmacologic, metabolic, and toxicologic profile of spirapril (SCH 33844), a new angiotensin converting inhibitor. J Cardiovasc Pharmacol 10(Suppl 7):S105-S108
40. Rimondini R, Thorsell A, Heilig M (2005) Suppression of ethanol self-administration by the neuropeptide Y (NPY) Y2 receptor antagonist BIIE0246: evidence for sensitization in rats with a history of dependence. Neurosci Lett 375:129-133
41. Rodriguez de Fonseca F, Roberts AJ, Bilbao A, Koob GF, Navarro M (1999) Cannabinoid receptor antagonist SR141716A decreases operant ethanol self administration in rats exposed to ethanol-vapor chambers. Zhongguo Yao Li Xue Bao 20:1109-1114
42. Hansson AC, Cippitelli A, Sommer WH, Fedeli A, Bjork K, Soverchia L, Terasmaa A, Massi M, Heilig M, Ciccocioppo R (2006) Variation at the rat Crhr1 locus and sensitivity to relapse into alcohol seeking induced by environmental stress. Proc Natl Acad Sci USA 103:15236-15241
43. Gehlert DR, Cippitelli A, Thorsell A, Le AD, Hipskind PA, Hamdouchi C, Lu J, Hembre EJ, Cramer J, Song M, McKinzie D, Morin M, Ciccocioppo R, Heilig M (2007) 3-(4-Chloro-2-morpholin-4-yl-thiazol-5-yl)-8-(1-ethylpropyl)-2,6- dimethyl-imidazo[1,2-b]pyridazine: a novel brain-penetrant, orally available corticotropin-releasing factor receptor 1 antagonist with efficacy in animal models of alcoholism. J Neurosci 27:2718-2726
44. Monti J, Schinke M, Bohm M, Ganten D, Bader M, Bricca G (2001) Glial angiotensinogen regulates brain angiotensin II receptors in transgenic rats TGR(ASrAOGEN). Am J Physiol Regul Integr Comp Physiol 280:R233-R240
45. Kasper SO, Carter CS, Ferrario CM, Ganten D, Ferder LF, Sonntag WE, Gallagher PE, Diz DI (2005) Growth, metabolism, and blood pressure disturbances during aging in transgenic rats with altered brain renin-angiotensin systems. Physiol Genomics 23:311-317
46. Voigt JP, Hortnagl H, Bader M, Fink H (2005) Effect of brain angiotensin on body weight. Behav Pharmacol 16:S66
47. Valdez GR, Roberts AJ, Chan K, Davis H, Brennan M, Zorrilla EP, Koob GF (2002) Increased ethanol self-administration and anxiety-like behavior during acute ethanol withdrawal and protracted abstinence: regulation by corticotropin-releasing factor. Alcohol Clin Exp Res 26:1494-1501